Oocyte competence is the ability of the oocyte to complete maturation, undergo successful fertilization, and reach the blastocyst stage. Cumulus cells are indispensable for this process. Their removal significantly affects the blastocyst rates. Moreover, the properties and functions of cumulus cells are regulated by the oocyte. They also reflect the oocyte's degree of maturation. Our study was aimed at identifying markers of oocyte competence that are expressed in bovine cumulus cells. In a previous study in our laboratory, the blastocyst yield following FSH or phorbol myristate acetate (PMA) treatment was 45%. Therefore, we tested four sets of conditions during the first 6 h of in vitro maturation (IVM): FSH (0
INTRODUCTION
As our understanding of factors regulating folliculogenesis increases, it appears the relationship between the oocyte and the surrounding somatic cells is more complex than previously thought and represents a determining factor of later developmental competence. It is currently established that communication between cumulus cells and their oocyte is essential for the competence acquisition process. In vitro culture of denuded bovine oocytes considerably decreases their competence [1] . Oocytes clearly depend on the presence of follicle cells to generate specific cellular signals that coordinate their growth and maturation. The cumulus cells were thought to express some of the signals that are crucial to the oocyte maturation fulfillment [2, 3] . The study of the gene expression in follicles, including cumulus and oocyte, may contribute to a better understanding of the maturation and the successful fertilization processes [4] .
Despite successful results of the in vitro maturation (IVM), the in vitro competence is still reduced compared with in vivoderived oocytes. Moreover, and because of the absence of appropriate analysis tools, the maturation completion is still assessed through successful fertilization and blastocyst yield. Bovine embryos produced in vitro show some differences with in vivo-derived embryos in terms of morphology, timing of development, resistance to low temperature, embryonic metabolism, and especially gene expression [5, 6] . Given that the morphological appearance of the oocyte and embryo does not accurately predict the health of the embryo [7] , studies of the gene expression in in vivo-and in vitro-maturing cumulusoocyte complexes (COCs) could potentially lead to the elucidation of signaling pathways involved in the intricate crosstalk between the oocyte and its somatic compartment during the maturation and the development processes, and to a better understanding of the origin of disturbances in oocyte maturation possibly involved in reduced fertility. Successful embryonic development is dependent on a rigorous, time-and site-specific gene expression program of appropriate genes. Identification of these differentially expressed genes and the analysis of their pattern of expression are powerful tools to gain information about functions relevant to processes such as the oocyte competence. Such further competence is mainly due to the molecular memory acquired during maturation by the oocyte and the surrounding somatic cells [8] . Thus, it is valuable to examine the gene transcription in both the oocyte and the cumulus cells when investigating developmental competence. Communication between the oocyte and cumulus cells is accomplished mainly through the gap junction type of intercellular communication. These communications are considered to play important roles in supporting oocyte maturation [9] . Previous studies have shown that the removal of the cumulus cells before IVM or the blockade of the gap junction were associated with an inhibition of oocyte maturation [10] . Moreover, cumulus cell expansion, gene expression, and other essential properties are governed by the oocyte and therefore reflect the follicle growth stage [11, 12] . Given the absence of FSH receptor on the oocyte, the study of cumulus cell responses to an FSH stimulation, especially the gene expression patterns, is therefore valuable. In addition, the presence of cumulus cells and intact gap junctions were reported to support oocyte competence in vitro [13] . Inhibition of the functional coupling between the oocyte and its cumulus using gap junction inhibitors significantly reduced the oocyte competence expressed in terms of blastocyst rate [14] . These findings support a key role for the cumulus and its communication with the oocyte in the competence acquisition process. Consequently, competent oocytes influence the pattern of expression of a set of biochemical markers in the cumulus that might be crucial to achieve maturation and successful subsequent development [15] .
Many studies have focused on gene expression in oocytes in order to find specific molecular markers to characterize successful oocyte maturation. Many genes were identified as potential predictors of oocyte competence [8, 16, 17] . Unfortunately, data on cumulus gene expression in the cow are lacking despite their established support to oocyte competence, a process that seems to be mediated by programs of differential gene expression. It is expected that some specific metabolites in the cumulus are indicators of the oocyte maturation state.
It was also previously demonstrated in our laboratory that during the first 6 h of IVM, FSH or phorbol myristate acetate (PMA) treatment led to improved oocyte competence and yielded more than 45% blastocysts [18] . Based on these results, the improvement in oocyte competence was thought to be mediated via gene expression in cumulus cells and then in oocytes. Hence, the present study aims to explore the transcriptional effect of FSH and/or PMA after 6 h of IVM on oocyte competence. Differentially expressed genes, especially those common to FSH-and PMA-treated extracts, were identified and could represent valuable molecular markers to predict oocyte competence through cumulus gene expression analysis. The identification of relevant subsets of these molecular cascades can provide powerful knowledge and new tools to individually assess oocyte competence by analyzing its cumulus. Moreover, these biochemical markers for embryo development would improve pregnancy outcomes by optimizing oocyte and embryo selection, especially in human IVF, and therefore allow fewer embryos to be transferred.
MATERIALS AND METHODS

COC Recovery and Cumulus Collection
Two groups of COCs were collected. In the first (in vivo) group, cows were synchronized and treated with FSH to induce superovulation. Briefly, the ovaries were collected 6 h after the GnRH-induced LH surge. The cows were presynchronized using an ear implant (3 mg norgestomet; Crestar; Intervet International BV, Boxmeer, Netherlands) for 9 days. Two days before implant removal, prostaglandin (22.5 mg; Intervet International) was administered to induce a new estrus cycle. From Days 9 to 14, cows received another Crestar implant, and FSH was administered twice a day in decreasing doses from Days 10 to 13. In addition to FSH, cows received prostaglandin 48 h before removal of the Crestar implant (Fig. 1) . Cows received an injection of GnRH (1 mg) at the time of implant removal and were ovariectomized 8 h after GnRH administration. Ovaries were collected in 0.9% (w/v) NaCl at 378C and were immediately transported to the laboratory [19] . Next, an individual preovulatory follicle (POF) selection was performed. POFs have decreased estradiol (E 2 ) and low progesterone (P 4 ) and testosterone levels in their follicle fluid. In vivo-derived cumulus was separated through gentle pipetting. We note that tissues of this first (in vivo) group were collected by Dr. Dielemann (Utrecht University, Utrecht, The Netherlands). Cows were reared in the Faculty of Veterinary Medicine's farm, and superovulation and ovariectomy protocols were achieved according to the recommendations of the Ethics Committee on Animal Experimentation at Utrecht University, The Netherlands.
In the second (in vitro) group, bovine ovaries were collected at a slaughterhouse and divided immediately into two subgroups before being transported to the laboratory: five ovaries were immediately put on ice, whereas the remaining ovaries were kept at 378C in a 0.9% (w/v) saline solution containing 100 000 IU/l penicillin, 100 mg/l streptomycin, and 250 lg/l amphotericin B (Sigma-Aldrich, Oakville, ON, Canada) and were used for an in vitro culture protocol. All further steps of cumulus collection in this group were performed at 48C. The COCs from 3-to 8-mm follicles were collected by aspiration. The 1, 2, and 3 classes of COCs were selected according to the morphological classification proposed by Blondin and Sirard [20] . Cumulus cells on ice were physically separated from immature COCs (germinal vesicle [GV] stage) by gentle pipetting and washed several times in PBS to prevent any contamination with oocyte content. Isolated and washed cumulus cells of this iced subgroup and from the in vivo group were then immediately frozen at À808C for subsequent RNA extraction and suppressive subtractive hybridization (SSH). Each IVM treatment and tissue collection for further molecular analysis was repeated four times.
FIG. 1.
Schedule of treatments for superovulation in cows with a fixed LH surge to collect in vivo-matured COCs (6 h after LH). FSH, Administration of eight consecutive, decreasing doses of FSH; PG, administration of prostaglandin; GnRH, administration of GnRH; LH surge, the time at which peak GnRH-induced LH surge occurs; DFP, dominant follicle punction.
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IVM and Cumulus Cell Collection at 6 h of IVM
Ovaries transported in saline solution were punctured, and only COCs with more than three layers of compact cumulus cells were selected using a stereomicroscope [21] . Selected COCs were washed three times in Hepesbuffered Tyrode medium (TLH) supplemented with 0.3% (w/v) BSA (fraction V), pooled into groups of 10 COCs, and then put into 50-ll droplets of maturation medium (SOF) with 0.8% BSA fatty acid free (Sigma-Aldrich) under 9 ml mineral oil (Sigma-Aldrich). To study the effects of recombinant human FSH (r-hFSH; Gonal F; Serono) and PMA (Sigma-Aldrich), four treatments were applied during the first 6 h of IVM. For each treatment, 40-50 COCs were used. Maturation occurred in saturated atmosphere humidity (5% CO 2 in air) at 38.58C for 22 to 24 h. The four treatments were: 1) SOF without hormone, 2) SOF þ r-hFSH (0.1 lg/ml), 3) SOF þ PMA (0.1 M), and 4) SOF þ FSH (0.1 lg/ml) þ PMA (0.1 lM). After 6 h of IVM, COCs from each treatment group were collected, and cumulus cells were physically separated from the oocyte (germinal vesicle breakdown stage) by gentle pipetting, washed by PBS, and then immediately frozen at À808C for further RNA extraction.
Total RNA Extraction
Total RNA of cumulus cells for in vitro-derived samples was isolated by Trizol extraction (Invitrogen, Burlington, ON, Canada) according to the manufacturer's protocol. The total RNA pellet was then resuspended in 30 ll nuclease-free water and stored at À808C. For in vivo-derived samples, RNA was extracted using Stratagene's RNA isolation kit (San Diego, CA) according to its users' manual recommendations. For both in vivo and in vitro replicates, total RNA quantification and quality assessment were achieved using an Agilent 2100 bioanalyzer (Agilent Technologies, Waldbronn, Germany) according to the manufacturer's protocol.
Construction of the SSH cDNA Library of the Cumulus from In Vivo Competent Oocytes
PCR-based RNA amplification. Because of the small amounts of starting material from bovine COCs, the mRNAs of the first (in vivo) and second (in vitro) groups of collected cumulus were reverse transcribed, and the full-length cDNA was subjected to PCR using the Super SMART PCR cDNA synthesis kit (Clontech, Mountain View, CA).
Protocols were performed according to the manufacturer's instructions. The reaction was stopped at 17 cycles. The amplified cDNA was then used for SSH.
Suppressive subtractive cDNA hybridization. The tester was the cDNA of in vivo-derived cumulus cells at 6 h after LH (oocytes at germinal vesicle breakdown stage), whereas the driver cDNA came from in vitro cumulus cells that were collected at the slaughterhouse and kept on ice. These driver transcripts came from 1, 2, and 3 classes of immature COCs (GV) from 3-to 8-mm follicles. The subtracted cDNAs were ligated into the pGEM-T plasmid vector (Promega, Madison, WI). The ligated product was then transformed into Escherichia coli DH5a-T1 cells (Invitrogen), plated on LB agar plates containing ampicillin (50 mg/ml) and X-gal (40 mg/ml), and incubated overnight at 378C. Recombinant white colonies were randomly selected and cultured in 96-well plates containing 150 ll LB broth with 50 mg/ml ampicillin for 6 h at 378C with agitation. The clones were amplified in a 50-ll reaction using 1 unit of HotMaster Taq DNA polymerase (Eppendorf), 10 mM dinucleotide triphosphates (dNTPs) in 13 buffer, and 30.8 ll nuclease-free water, as well as 0.25 lM nested primers 1 and 2R.
Sequencing and BLAST homology search. The PCR products were purified using the unifiltered 384-well purification plates (Whatman, Clifton, NJ) and then sequenced using nested primer 1 with the ABI 3730 DNA sequencer and the ABI prism BigDye Terminator Cycle Sequencing Ready Reaction Kits (Applied Biosystems, Foster City, CA). The resulting sequences were analyzed using the Chromas software [22] , then blasted using cDNA Library Manager, a server of Genome Canada Bioinformatics that allows clone identification using the GenBank database as reference [23] . The BLAST results, including GenBank accession number, Unigene number, score, e-value, homologous nucleotide alignment, and position of alignment were finally compiled in a report chart.
Microarray Printing
A homemade microarray containing the PCR products of our partial library composed of randomly selected clones (n ¼ 405) was performed using the VersArray ChipWriter Pro (BioRad, Mississauga, ON, Canada). Each selected clone was spotted in two replicates on GAPS II glass slides (Corning, Corning, NY). Various controls were printed on the slide: SpotReport Alien cDNA Array Validation System (Stratagene) as negative control, the GFP (green fluorescent protein) gene as an exogenous positive control, and housekeeping genes (ACTB and GAPDH) as internal positive controls. Slides were then cross-linked with ultraviolet rays according to the manufacturer's instructions. Quality control printing was achieved with Terminal Transferase dye (Roche Diagnostics, Laval, QC, Canada) according to manufacturer's instructions.
Hybridization of Cumulus Cells Collected at 6 h In Vitro
Linear amplification of RNA. For the cumulus cells collected after 6 h of IVM, RNA amplification was achieved using 2-round IVT (in vitro transcription) following the instructions of the RiboAmp RNA Amplification kit (Arcturus LCM Instruments; Molecular Devices, Sunnyvale, CA). The amplification product was eluted in 30 ll RNA elution buffer, and 1 ll was used to quantify the antisense RNA (aRNA) amplification yield using the NanoDrop (Wilmington, DE).
RT and cDNA precipitation labeling. Briefly, 3 lg aRNA from each IVM treatment was reverse transcribed using 50 lM of random primers (Ambion), dNTP mix (10 mM dATP, dCTP, and dGTP; 3 mM TTP; and 6 mM dUTP), according to the Superscript III RT kit (Invitrogen, Carlsbad, CA) instructions. An alkaline hydrolysis of the RT product with 1 N NaOH for 10 min at 708C was then performed, followed by neutralization with 1 N HCl. Twenty microliters of sodium acetate (3 M, pH 5.2) was then added to each tube, and the final volume was adjusted to 100 ll with nuclease-free water. Purification was performed using the Qiaquick PCR purification kit (Qiagen) according to the manufacturer's instructions, except that the washing step was repeated three times, followed by isopropyl alcohol precipitation. Briefly, 3 ll sodium acetate (3 M, pH 5.2) and 150 ll isopropyl alcohol (100%) were added to each treatment before incubation for 30 min at À808C. The pellet was washed with 500 ll of 70% ethanol and resuspended in 5 ll of nuclease-free water.
Since the SOF without hormone treatment served as a hybridization reference, 9 lg aRNA was reverse transcribed and labeled.
Complementary DNA indirect labeling, purification, and precipitation. The cDNA labeling was performed using a two-step method with fluorescent Alexa Fluor 647 and 555 dyes (Molecular Probes, Eugene, OR). Sodium bicarbonate (0.1 M, pH 9) was added to each treatment's amino allyl cDNA as a labeling buffer, and the mix (8 ll) was added to the Alexa Fluor dyes already dissolved in 2 ll dimethylsulfoxide, and incubated in the dark for 1 h. The three IVM treatments (PMA, FSH, and FSH þ PMA) were labeled with the 647 dye, whereas the control treatment (SOF without hormones) was labelled with 555 dye. Probes were purified using a PCR purification kit (Qiagen) according to the instructions, washed three times, and then eluted in 50 ll nuclease-free water. Isopropyl alcohol precipitation was carried out as described above. The precipitated probes were resuspended in 8 ll of 10 mM EDTA for the three treatments and 24 ll for the control.
Quality and quantity of labeling assessment. A 1-ll aliquot of the final eluate of the purified labeled cDNA of each treatment was assessed on the NanoDrop. Each two differentially labeled probes (using Alexa Fluor 555 and 647 reactive dyes) used for hybridization on the same microarray slide were then mixed together in equimolar proportions.
Probe hybridization and microarray analysis. Three hybridizations were performed on the custom-made array containing the PCR-amplified cDNA inserts in order to select potential candidates for quantitative PCR validation: FSH (647) versus control (SOF without hormones; 555) PMA (647) versus control (555) FSH þ PMA (647) versus control (555) Hybridizations were performed in the ArrayBooster using the Advacard AC3C (The Gel Company, San Francisco, CA) for 18 h at 558C using Slide Hyb#1 (Ambion, Austin, TX). The slides were then washed twice in 23 salinesodium citrate (SSC)/0.5% SDS buffer for 15 min at 558C and twice in 0.53 SSC/0.5% SDS buffer. Two quick final washes at room temperature in 13 SSC and water were achieved before a spin dry for each slide in a centrifuge at 900 3 g for 5 min. The arrays were then scanned and analyzed using the ChipReader and ArrayPro Analyzer software (Media Cybernetics, San Diego, CA).
Microarray data were normalized (Loess normalization) using the ArrayPro and were background subtracted to eliminate uninformative data and to define a calculated threshold (t). This value was calculated as t ¼ m þ 2 3 SD, where m is the mean of the negative control raw data and SD is the standard deviation, and then used to select clones that were subsequently used in data analysis. Finally, 647:555 ratios were used to obtain a list of candidates for each hybridization, as well as common positive candidates between treatments (i.e., FSH vs. PMA, FSH vs. FSH þ PMA, and PMA vs. FSH þ PMA) were selected for further analysis and quantitative real-time PCR validation.
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Quantification by Real-Time PCR
Nonamplified aliquots of our four biological replicates that were used for hybridization were analyzed by real-time PCR. This quantification analysis was performed using a two-step RT-PCR. The single-stranded cDNA templates for real-time PCR analysis were generated from 50 ng nonamplified total RNA samples by reverse transcription using Sensiscript RT (Qiagen) and an oligo dT according to the manufacturer's instructions. Samples were diluted to 80 ll for subsequent real-time PCR in a LightCycler instrument (Roche) using the LightCycler FastStart DNA Master SYBR Green I (Roche), according to the manufacturer's instructions. Each gene was amplified with specific primers. Primer sets were designed using Primerquest software (Integrated DNA Technologies, Coralville, IA) [24] . Primer sets are summarized in Table 1 . Quantification analysis was based on a standard curve produced using series of four dilutions of a standard purification for each studied gene ranging from 2 3 10 À4 to 2 3 10 À7 ng per reaction. The following settings in the LightCycler PCR were used: a preincubation step (10 min at 958C) and a three-step cycling amplification (50 cycles): denaturation (5 sec at 958C), annealing (5 sec at T m of each primer set), and extension (20 sec at 728C). Melting curves were performed by cooling the samples down to 728C and then increasing the temperature to 958C (with a slope of 28C/sec). Results were quantified using the relative quantification approach with the software provided by the manufacturer (Roche). GAPDH, actin beta (ACTB), and polyubiquitin were used as internal controls.
Statistical Analysis
Each real-time PCR experiment was performed using four biological replicates, and data were normalized using the GeNorm software (PRimerDesign Ltd., Southampton, UK) [25] as described by Vandesompele et al. [26] . Briefly, we used a set of three candidates composed of GAPDH, ACTB, and polyubiquitin to choose our reference genes. Using the GeNorm software, we obtained the most stable reference genes, that is, GAPDH and ACTB, as well as the appropriate normalization factors using the the 2 (ÀDelta Delta C(T)) method [27] . The mRNA quantities of analyzed candidates were then divided by preceding normalization factor and transformed (log base 10), and a one-way ANOVA using GraphPad PRism4 software (GraphPad Software, San Diego, CA) was performed. Multiple comparisons were performed with Tukey test (P , 0.05).
RESULTS
Identification of Differentially Expressed Clones Using SSH
Suppressive subtractive hybridization between the tester transcripts (cDNA of in vivo-derived cumulus cells 6 h after LH) and the driver cDNA (in vitro cumulus collected on ice) provided us with valuable differentially expressed genes that covered a wide range of maturation steps, from medium-size growing follicles to 6 h post-LH stage. A total of 419 clones were sequenced and blasted against the known sequences in the GenBank database. After identification step based on nucleotide homologies, 300 different clones were selected and printed on slides. For slide description and clone printing, they were described elsewhere by Hamel et al. [28] .
Microarray Analysis of IVM Treatments
Each of the three treatments (FSH, PMA, and FSH þ PMA) was hybridized against the control treatment. Microarray normalized data were analyzed, and candidates with the highest hybridization ratio were selected. Candidates common to two treatments or to all three treatments taken together were selected (Fig. 2) . Because of the poor RNA quality of the FSH þ PMA IVM replicate when assessed with the bioanalyzer before amplification, another series of IVM replicates for the fourth IVM treatment had to be performed. To prevent bias, the control sample of the second series of IVM treatment replicates (named CTRL2) was added to the FSH þ PMA sample in the real-time PCR validation step. Real-time PCR analysis was therefore based on CTRLI, FSH, and PMA from the first series of replicates, and CTRL2 and FSH þ PMA from the second series.
Microarray analysis provided us with a nonexhaustive list of differentially expressed genes per treatment. Twenty-four candidates were common to the three IVM treatments (Table  2 ). These common genes represented 48%, 30%, and 15.5% of the differentially expressed candidates in the FSH, PMA, and FSH þ PMA treatments, respectively. Common candidates were chosen based on the ability of FSH, PMA, and FSH þ PMA to increase oocyte competence and, hence, blastocyst yield. The three treatments seemed to induce the oocyte competence molecular process through the expression of a set of genes in cumulus cells. Therefore, suitable potential markers associated with oocyte competence should be differentially expressed in all three IVM treatments ( Table 2 ). Some of these 24 common candidates were subjected to further RT-PCR validation.
Analysis of mRNA Expression by Real-Time PCR
Real-time PCR quantification was used to validate differentially expressed genes in cumulus cells. Three main criteria were used to select clones to be confirmed by quantitative PCR in this study: 1) the hybridization ratio and the redundancy of each clone in our SSH library, 2) its function as a potential target of the FSH and/or the protein kinase C (PKC) pathways, and 3) a gene-candidate approach, that is, certain candidates that were not in our library but were reported by others to be expressed in the cumulus of competent COCs. A total of 15 candidates were selected for real-time PCR validation. There were seven candidates from the overexpressed genes that were common between our three in vitro fertilization (IVF) treatments (HAS2, INHBA, TNFAIP6, HSP90AA1, THBS, EREG, and HSP90B1). The eight other candidates were chosen according to criteria 2) and 3) (CD44, EGFR, BTC, PTGS2, PGR, SERPINE2, GREM1, and PTX3; Fig. 3 ). To reveal actual differences in gene expression, we used multiple-comparison statistical analysis (Tukey test, a ¼ 0.05) to classify gene level expression among the four IVM treatments.
Analysis of the expression profiles of cumulus cells after 6 h of IVM revealed six major patterns of gene expression: 1) FSH specific without additive effect with PMA; 2) PMA specific 
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without additive effect with FSH; 3) PMA specific with additive effect with FSH; 4) both FSH and PMA specific with additive effect; 5) both FSH and PMA specific without additive effect; and 6) neither FSH nor PMA specific. The latter pattern contained two subgroups depending on whether or not the additive effect was significant. Compared with control (hormone-free) treatment after 6 h of IVM, 43% of candidates (7 of 16 genes) were differentially expressed in the FSH treatment, including HAS2 (a , 0.05), INHBA (a , 0.001), TNFAIP6 (a , 0.05), the hyaluronan receptor CD44 (a , 0.01), GREM1 (a , 0.05), EGFR (a , 0.01), and BTC (a , 0.05). For PMA treatment, PGR (a , 0.01), HAS2 (a , 0.01), INHBA (a , 0.001), GREM1 (a , 0.05), EGFR (a , 0.01), the protein chaperone HSP90AA1 (a , 0.05), THBS (a , 0.01), and HSP90B1 (a , 0.05) were the major differentially expressed genes. The additive effect between FSH and PMA was studied via the IVM treatment PMA þ FSH. Differentially expressed genes were significant compared with either FSH and/or PMA treatment and with the control treatment. This was the case for more than 45% of the candidates (Fig. 3) . Four candidates were not differentially expressed among the four treatments: EREG (P ¼ 0.54), PTX3 (P ¼ 0.16), and PTGS2 and SERPINE2, which were only differentially expressed in the FSH þ PMA treatment compared with PMA and FSH, respectively (Fig. 4) .
DISCUSSION
SSH and Library Construction
Suppressive subtractive cDNA hybridization has been used as a powerful tool to both isolate and identify cDNAs of differentially expressed genes. It has the advantage of enriching low-abundance transcripts, which are differentially expressed in the tester population [29] . For these reasons, we opted for SSH as a suitable tool for the realization of our experience.
The role of cumulus cells in supporting oocyte maturation and competence acquisition is well established [10, 30] . Furthermore, the major transcriptional activity of the oocyte occurs during meiotic arrest before ovulation (GV) [31] . In order to better understand the cumulus functions related to oocyte competence improvement, we looked for differentially expressed genes between cumulus cells collected in vivo at 6 h after LH (tester) and those collected on ice (driver) at the slaughterhouse (cumulus of immature oocytes at GV stage) using SSH technology. The aim was to keep the driver's COCs at their minimal level of maturation and to avoid the beneficial effect of transportation in saline solution at 308C on oocyte competence [32] . On the other hand, cumulus cells collected following the LH surge (tester) are believed to contain the whole set of transcripts and proteins required to allow the final maturation of the oocyte. All of these facts supported the idea that the 6-h post-LH peak is the optimal moment to study gene expression in cumulus cells to find potential markers associated with oocyte competence.
Microarray Analysis
Using the LH surge as reference, the corresponding time after aspiration to look for cumulus response was set at 6 h [33] . Four treatments were performed in order to explore, using microarrays, the genomic effect of FSH, PMA, and their eventual additive effect (FSH þ PMA) during the first 6 h of IVM that enhances oocyte competence. The choice of these treatments was made according to previous findings that showed that both rFSH (0.5 lg/ml) and PMA (0.1 lM) added at 6 h of IVM improved oocyte competence and yielded more than 45% of blastocysts [18] . Since cumulus cells are essential for normal development in vivo and in vitro through continuous association with the oocyte, their pattern of mRNA expression might represent an efficient and indirect alternative to assess oocyte competence [34] . Moreover, a positive correlation between specific gene expression in human cumulus and subsequent embryo development was reported [35] . In addition to their usefulness in improving COC selection, these differentially expressed molecular signals may constitute a sign of oocyte competence or fulfilment of maturation, and their expression pattern is reported to be regulated by the oocyte itself in many species [2, 12, 36, 37] . Because of this crossdialogue between cumulus and oocyte as well as the fact that FSH and PMA led to the same improvement in blastocyst yield, it was expected that common candidates revealed by these hybridizations would likely be associated with the molecular process of acquisition of competence.
The analysis of the physiological processes covered by common hybridization candidates revealed at least seven major functions. Cell defense and regulation of apoptosis was one of the main cellular processes in which hybridization candidates were involved. This process includes antioxidative stress response, DNA repair, heat shock protection, and immune and anti-inflammatory responses (e.g., GSTA1, UTMP, HSP90AA1, and HIGD1A). The other major cellular processes were signal transduction (AKAP7 and EREG) and cell structure and communication, including extracellular matrix formation (TNFAIP6 and ADAMTS1), cell adhesion, and molecular export. In contrast, cell cycle was limited to only 4% of the common candidates (Fig. 5) . This cellular process distribution appears to make sense in light of cumulus cell differentiation and functions. In fact, apoptosis incidence in the outer layers of cumulus cells was reported as a morphological criterion correlated with oocyte competence enhancement [20] . Cumulus cells were also found to protect porcine oocytes against oxidative stress-induced apoptosis by enhancing glutathione (GSH) content in oocytes and to express many immune cellrelated genes that are indispensable to the inflammatorylike response preceding ovulation [38, 39] . Thus, a cumulus cell expression pattern related to defense and apoptotic response may be considered a sign of oocyte final maturation progression just prior to ovulation [40, 41] . In the case of signal transduction, it has been demonstrated that cumulus cells represent a signalling interface between the oocyte and its surrounding environment. This cellular process is believed to play a key role in the oocyte competence acquisition through a functional signaling cascade in both the somatic and germinal compartments of the follicle [42] . Among the main documented functions attributed to cumulus cells were extracellular matrix expansion and ''ovulation processes'' [43] . This is supported by the fact that many candidates related to the cumulus expansion process were differentially expressed after 6 h of IVM. For cell cycle, cumulus cells are differentiated and specialized cells that divide in a very coordinated way related 
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to maturation progression. Their mitotic index is reported to decrease with maturation progression in mouse and to stop at around 8 h of culture [38] . The main common biological function in which these candidates are involved is reproduction or fertility in general, including estrus cycle, cumulus expansion, ovulation, embryo nidation, development of early pregnancy, and embryogenesis.
Real-Time PCR Analysis
The relative expression level of each candidate in each IVM treatment is summarized in Figure 4 . Interestingly, we note the absence of an FSH-specific pattern with additive effect with PMA. This is a strong indication that the effect of FSH probably involves most of the pathways induced by PMA, whereas the converse is false. Under this assumption, the response to FSH appears to be more general and complete than the response to PMA. The PMA effect may be considered as a principal pathway included in FSH action on cumulus cells to reach oocyte competence.
The first pattern observed following FSH treatment and that included an FSH effect without a PMA additive effect (Fig.  3A) is illustrated mainly by TNFAIP6, CD44, BTC, and PTGS2. TNFAIP6 expression was detected under inflammatory conditions in vivo. It is induced by proinflammatory cytokines in a variety of cell types in vitro and has anti-inflammatory and chondroprotective effects [44] . The TNFAIP6 protein can also interact with molecules that form the backbone of the COC matrix, such as hyaluronan (HA), through its Link module and inter-a-trypsin inhibitor (IaI) [45, 46] . Its expression was reported to occur upstream of Ptges2, especially Ptgs2 and/or Ptger2 (prostaglandin E receptor 2), in mice, and was induced by FSH through the cAMP/PKA/ERK [47, 48] pathway, supporting our current findings. Moreover, TNFAIP6-deficient mice (Tnfaip6 À/À ) failed to assemble the extracellular matrix of COCs in vivo due to the lack of HA incorporation and were infertile [49] . These characteristics suggest a key role for TNFAIP6 in the organization of the extracellular matrix and ovulation.
CD44 is a cell adhesion receptor with HA as one of its main ligands in the viscoelastic extracellular matrix. It is a normal component of extracellular matrix and fluids and is mainly involved in cell adhesion and/or migration, inflammatory responses, and apoptosis inhibition [50] [51] [52] . Expression of the CD44 mRNA increased during bovine IVM of COCs under either LH or FSH þ LH treatments [53] , possibly through the PKA/Raf/MEK1,2/ERK1,2 pathway, as proposed for the salivary gland [54] . Possible transactivation of receptor tyrosine kinases (mainly EGFR) after G-protein stimulation may also induce CD44 expression through Gai-and/or Gbcmediated signaling pathway [55] . CD44 was suggested as a candidate related to bovine oocyte maturation in vitro [56] and is differentially expressed in human cumulus of mature COCs compared with their immature counterparts [57] .
PTGS2 is an enzyme that catalyzes the conversion of arachidonic acid into PGH 2 and various specific prostaglandins. It is involved in several female reproductive functions, such as ovulation, fertilization, pregnancy, and parturition [58] . Its expression is induced by gonadotropins during the preovulatory stage. Furthermore, the interval from expression induction to follicular rupture was around 10 h in rat, cow, and horse [59] . Ptgs2 À/À mice exhibited impaired cumulus expansion and had severely reduced ovulation rates. Ptgs2 is essential to induce Tnfaip6 expression in cumulus cells. In fact, Ptgs2 or Ptger2-null mice exhibit an important decrease in Tnfaip6 mRNA, which leads to an impaired cumulus matrix and infertility [48] . In human cumulus cells, a 6-fold increase in PTGS2 expression in competent COCs was reported, hence its proposed role as a marker of human oocyte competence [35] . This increased expression was induced by either the PKA pathway or epidermal growth factor (EGF) and was reported to be synchronized with cumulus expansion progression in bovine COCs [60, 61] . Taken together, these data support the FSHstimulated expression of PTGS2 in bovine cumulus cells in vitro through PKA. PTGS2 expression may be also amplified through EGF-like factors (EREG, AREG, and BTC).
BTC belongs to the EGF family, as does EREG. Although there was an additive effect of FSH and PMA on EREG expression, it was not enough to be significant (data not shown). BTC expression was significantly higher in FSH than PMA without any additive effect. The expression of these EGF-like factors was triggered by gonadotropins, in particular LH through the activation of the cAMP cascade [62] . These growth factors induced the main morphological and biochemical events initiated by pituitary hormones, including cumulus expansion, oocyte maturation, and luteinization, upon incubation with follicles [63] . These factors are therefore paracrine mediators that propagate the FSH and LH signals throughout the mammalian ovulatory follicles. Their expression in granulosa cells was associated with dominant follicles in rat and cattle [64, 65] . In mouse cumulus cells, their expression increased dramatically after 4 h of culture in FSH-enriched media, which required EGFR expression and was downstream of the p38MAPK pathway [40] . BTC and EREG are thereafter synthesized as integral membrane precursors with a single 216 transmembrane domain and, in order to be biologically active, they must be cleaved by members of the A Disintegrin And Metalloproteinase (ADAMs) family. The mature proteins are subsequently able to bind to EGFR and activate downstream pathways, mainly ERK1/2 [66] . They were also reported to act through the cAMP/PKA pathway [67] . Our data confirm the expression of these factors in cumulus cells and reveal for the first time their differential expression following treatment with FSH. Their role in cumulus expansion, steroidogenesis, and ovulation [68] indicates BTC and EREG are putative indicators of further development competence. Based on our results, the FSH-specific expression of BTC in cumulus in vitro suggests it is a more likely marker of oocyte maturation progression than EREG.
The second pattern (Fig. 3B) we observed included genes induced specifically by PMA without additive effect with FSH. Representative genes include THBS (thrombospondin) and HSP90B1 (heat shock protein 90 kDa beta, member 1). THBS belongs to a family of five multidomain glycoproteins and is involved in cell-cell and cell-matrix interactions through a calcium-dependent pathway, as well as in angiogenesis inhibition [69] . In the rat ovary, THBS expression was induced by FSH in cultured granulosa cells compared with control [70] and was suggested to maintain avascular granulosa in mammal preantral follicles [71] . The THBS expression pathway was reported to be induced by PMA and/or PKC pathway in hepatocarcinoma cell lines [72] . In fact, PMA is an inducer of the PKC pathway through a DAG-like process, which leads to IP3-calcium release from the endoplasmic reticulum or the extracellular media. These data, taken together with our results, suggest important roles for THBS in cumulus cells, such as angiogenesis control and extracellular matrix stabilization. PMA and, more generally, the PKC pathway, appear to be the appropriate inducer of THBS expression in bovine cumulus cells in vitro.
HSP90B1 (also known as TRA1) and HSP90AA1 are two chaperones that belong to the HSP90 family and are involved in many cellular functions, such as protein folding, cell signaling, transcription, kinase regulation, and DNA replication and repair [73] . Our results showed that these two chaperones share similar expression patterns, with a significant effect of PMA and not of FSH. The additive effect of FSH and PMA was significant only for HSP90AA1. This supports a slight improvement of their expression under FSH treatment. Given that PMA is a potent activator of PKC and may activate inflammation-related events in vitro, its action in the cumulus may be the result of increased HSP90AA1 expression and mRNA stability, as reported in human monocytes [74] . HSP90B1 also has some specific functions, such as folding and assembly of proteins in the ER, monitoring of protein transport through the cell, and protection against cell death [75] . In bovine dominant follicles, HSP90AA1 was proposed as a regulator of follicular maturation through its action on aromatase [76] . HSP90B was also found to be expressed on the sperm surface, which may mediate its interactions with cumulus cells, the extracellular matrix, and the oocyte plasma membrane during fertilization [77] . The association between the oocyte maturation process and chaperone expression seems to be necessary to protect the oocyte, prevent cumulus cell apoptosis, support signal transduction, and prepare the inflammatorylike ovulation process.
In addition to HSP90AA1, the other candidates from the pattern (Fig. 3C) were PGR and SERPINE2. PGR expression is induced by gonadotropins, mainly LH, hCG, or eCG. It was reported to be essential in reproduction and particularly in the ovulatory process through stimulation of the expression of enzymes crucial to ovulation, such as ADAMTS1 and CTSL (cathepsine L), and inhibition of cell apoptosis [78] . PGR is differentially expressed in the granulosa of periovulatory follicles [79] . Despite previous findings indicating the absence of PGR expression in the cumulus before the LH surge [80] , our results indicate it is expressed in cumulus cells in vitro, especially following PMA treatment. This effect was additive when PMA was combined with FSH. The detailed expression pathway of PGR is still unknown.
SERPINE2 is a proteinase inhibitor regulated mainly during the transcriptional process. Its expression increased with follicle growth progression and was maintained in the corpus luteum. SERPINE2 mRNA is regulated in a spatiotemporal pattern, with the highest levels in granulosa cells of growing dominant bovine follicles and follicle fluid [81] . This supports the hypothesis that high expression of SERPINE2 may contribute to final follicular growth and, therefore, increased oocyte competence. It is also involved in the remodeling of the extracellular matrix of bovine granulosa cells during antral follicle growth and may have an antiapoptotic role [82] . This chronology of expression suggests an important role for SERPINE2 in cumulus extracellular matrix organization. Our data confirm the expression of SERPINE2 in bovine cumulus cells in vitro downstream of the PMA pathway.
The next pattern (Fig. 3D ) is represented by HAS2, which showed both FSH and PMA effects that were additive. In fact, HA is a glycosaminoglycan with antioxidative activity. Its synthesis by mouse cumulus cells was first detected 2-3 h after 
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gonadotropin stimulation, reached and maintained a maximum rate at 4-10 h, and declined and ceased by about 18 h [83] . The main enzyme responsible for HA production by cumulus cells is HAS2 [53] . The timing of HAS2 mRNA expression in cumulus cells correlates well with HA synthesis [84] . HAS2 expression was also proposed to be under the control of GDF9 (growth and differentiation factor 9) [85] and considered an important prerequisite for initiating HA-mediated effects during final oocyte maturation, as well as sperm-egg interactions [53] . HAS2 is differentially expressed in the cumulus of human competent COCs [35] . All these arguments suggest HAS2 is a potential marker of oocyte competence. Concerning the expression pathway, our data confirmed the FSH stimulation of HAS2 expression through cAMP/PKA [83, 86] . We reported also an additional pathway via PKC that is probably mediated through EGFR tyrosine kinase activity. In fact, Tirone et al. [83] reported the absence of any effect of EGF stimulation on cAMP levels in mouse cumulus cells, which supports the idea of two complementary pathways.
The pattern (Fig. 3E) where we observed nonadditive effects of FSH and PMA contains three candidates: INHBA, EGFR, and GREM1. INHBA is one of two a:b heterodimers that are members of the TGFB (transforming growth factor b) superfamily. Measurement of INHBA serum levels during human follicle growth showed a basal level secretion that increased for 1-2 days throughout the FSH treatment during maturation progression. It was suggested that the serum levels of INHBA have a predictive value in monitoring ovarian stimulation treatment for IVF and, hence, to assess the rate of healthy oocytes for selection for IVF [87] . INHBA expression is differentially upregulated in granulosa cells of sheep and cattle competent follicles [88, 89] . INHBA mode of action is not yet fully understood, although some models have been proposed.
EGFR is the receptor for EGFs. Its expression increased with progression of folliculogenesis due to gonadotropin stimulation, reached its maximum at the preovulatory stage, and was modulated through the MAPK and PI3K pathways [90] . It was also reported in rat granulosa cells and bovine cumulus [63] , which is consistent with our findings. Seven members, including EGF, TGFA (transforming growth factora), HB-EGF (heparin-binding epidermal growth factor-like growth factor), AREG, EREG, and BTC were reported to be EGFR ligands [91] . The PLC/IP2/PKC pathway is one of the main EGFR signaling pathways [92] . Its intracytoplasmic domain has tyrosine kinase activity that induces PLC and, therefore, intracellular calcium, PI3 kinase, and MAPK. The EGF's antiapoptotic effect and activation of the PI3K pathway through RAS-RAF-MEK-ERK were reported in pig cumulus cells [93] . This MAPK/ERK signaling pathway, which is independent of PKA and downstream of EGFR, was also reported in chicken granulosa cells and in murine cumulus cells [40, 94] . Interestingly, EGFR amplifies both the FSH and the PMA gene expression pathways. Once expressed, EGFR can induce other pathways (whether by its autophosphorylation or when activated by cleaved EGF-like factors), mainly through ERK1/2 [91, 95] .
GREM1 is an antagonist of bone morphogenic protein (BMP) signaling but not of the GDF9 pathway. Its expression was associated with competent oocytes in preovulatory human cumulus cells and reported to be downstream of the GDF9 pathway [35] . The differential regulation of BMP through GREM1 is thought to contribute simultaneously to granulosa cell luteinization and cumulus cell expansion, and therefore to the final maturation of oocytes [96] . Considering that GREM1 inhibits BMP15, an oocyte-derived factor, the oocyte exerts a meticulous control on gene expression in the somatic compartment, especially in cumulus cells [96] . GREM1 therefore reflects the BMP15 activity and was suggested to be a predictor of oocyte competence.
The last pattern (data not shown) includes candidates with neither FSH-nor PMA-specific effect. This pattern contains two subgroups according to whether there was a significant additive effect, such as SERPINE2, or no effect for all four IVM treatments, which was the case for PTX3 and EREG. Both SERPINE2 and EREG were discussed before. PTX3 encodes an acute-phase protein of 45 kDa that acts downstream of GDF9 [97] and is expressed in anti-inflammatory responses [98] . PTX3-null mice were subfertile despite their ability to ovulate with impaired cumulus cell mucification [99] . Its expression pattern was similar to TNFAIP6, and their coexpression seems to be crucial for matrix stability and mouse fertility in vivo. It was induced by primary inflammatory signals, hCG, FSH, cAMP, and EGF, depending on the cellular type, and was reported in mouse and human cumulus cells during the preovulatory phase in vivo [98, 100, 101] . Recently, a direct interaction between PTX3 and IaI was reported [102] . This provided further confirmation of its essential role in cumulus viscoelastic matrix stabilization prior to ovulation. Although Zhang et al. [103] suggested PTX3 was a marker of oocyte quality and, hence, of its competence, our data reported a similar expression of PTX3 in the cumulus following the four IVM treatments. This may be due to the difference in collection time of cumulus cells. Although our real-time PCR analysis was at 6 h of IVM, Zhang et al. [103] used human cumulus cells matured in vivo. It is possible that PTX3 expression continues to increase until ovulation in order to ensure maximal cumulus expansion and contribute to fertilization [104] . In addition to the possible differences between species, there may be differences between in vitro and in vivo conditions. Thus, we speculate that PTX3 expression is basal or ubiquitous at 6 h in vitro, independently of IVM treatment. Under these conditions, PTX3 appears to be an inadequate marker of oocyte competence.
Candidates analyzed in the present study have provided us with the expression pattern of 15 genes. At least eight of them could be potential candidates to predict oocyte competence (Fig. 4) . To our knowledge, these candidates are reported for the first time together in bovine cumulus in vitro. As mentioned before, the most interesting candidates are those with FSHspecific, PMA-specific, and FSH þ PMA additive effects. This conclusion emerges from the IVF results, where the three treatments gave statistically similar blastocyst levels. Thus, the different effects induced by FSH, PMA, or both (FSH þ PMA) are very important to better understand the contribution of these pathways, in particular PKC, to the process of oocyte maturation and subsequent fertilization. Based on our results, the major candidates expressed in cumulus cells in vitro at 6 h of IVM and that could constitute a valuable set of oocyte competence markers are HAS2, INHBA, EGFR, GREM1, BTC, CD44, TNFAIP6, and PTGS2.
EGFR is, therefore, a major contributing factor to PMAinduced transcription [105] . STAT3 and SP1 are the main transcription factors activated downstream of PMA action [93, 106] . Transcriptional activation by PMA should be achieved through two pathways, PKC/Ras/Raf/MEK/ERK or PKC/ MEK/ERK. The latter pathway [107] may represent the vectors of PMA-specific, FSH-independent transcription. Additive effects between FSH and PMA could be modulated through the PI3K/Akt pathway (Fig. 6) .
Extending these studies to identify differentially expressed genes in vivo will be a valuable tool to compare with candidate genes identified in vitro. Together, these findings will contribute to a better understanding of the cumulus contribution in the molecular mechanisms that lead to oocyte competence acquisition. The differentially expressed genes may be important markers of the oocyte's ability to reach the blastocyst stage and allow direct assessment of the fertility potential of an individual oocyte without compromising its integrity.
